Overview
Pre-emptive Analgesia With Qutenza in Lower Limb Amputation
Status:
Unknown status
Unknown status
Trial end date:
2014-05-01
2014-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Neuropathic (nerve pain) following amputation of a limb is very common, affecting 60-80% of patients (Sherman et al, 1984). It can prolong their recovery making it difficult to fit protheses and mobilise. Current treatment options are limited and existing painkillers have significant side effects. Nevertheless there is some evidence that pre-emptive analgesia (pain relief provided prior to the surgery) has additional benefits after the surgery (Ypsilantis & Tang, 2010) Qutenza (topical capsaicin 8%)is a novel analgesic agent which is applied directly onto the skin. It works by desensitising to pain receptors in the skin (Nolano et al., 1999) and has been shown to be effective in reducing neuropathic pain in other conditions (Backonja et al., 2008) We propose to evaluate the use of Qutenza for pre-emptive analgesia in patients undergoing amputation of a limb. This is a small, pilot, randomised controlled study of 30 patients undergoing lower limb amputation who will have Qutenza or active control applied prior to surgery. They will be followed up for 12 weeks post-operatively with regular assessment of pain scores, quality of life and wound healing.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
NHS Greater Glasgow and ClydeTreatments:
Capsaicin
Criteria
Inclusion Criteria:- All adult patients >18 years old undergoing lower limb amputation
Exclusion Criteria:
Traumatic amputation Severe active sepsis in non-viable limb Illness necessitating urgent
surgery <24 hours after admission to hospital Hypersensitivity to Qutenza, Emla or any of
the excipients Broken skin or active ulceration at the site of application Severe
uncontrolled hypertension (systolic BP >200) Proven cardiac event during the preceding 3
months Women who are pregnant or breast feeding Lack of capacity or inability to provide
informed consent Declines participation in the study